0001209191-21-048255.txt : 20210726 0001209191-21-048255.hdr.sgml : 20210726 20210726202921 ACCESSION NUMBER: 0001209191-21-048255 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210723 FILED AS OF DATE: 20210726 DATE AS OF CHANGE: 20210726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Collins Cynthia CENTRAL INDEX KEY: 0001405692 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39376 FILM NUMBER: 211115629 MAIL ADDRESS: STREET 1: 65 WEST WATKINS MILL ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Poseida Therapeutics, Inc. CENTRAL INDEX KEY: 0001661460 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 472846548 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9390 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-779-3100 MAIL ADDRESS: STREET 1: 9390 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-23 0 0001661460 Poseida Therapeutics, Inc. PSTX 0001405692 Collins Cynthia C/O POSEIDA THERAPEUTICS, INC. 9390 TOWNE CENTRE DRIVE, SUITE 200 SAN DIEGO CA 92121 1 0 0 0 Stock Option (Right to Buy) 8.63 2021-07-23 4 A 0 87440 0.00 A 2031-07-23 Common Stock 87440 87440 D The stock option will vest and become exercisable in 36 equal monthly installments following the grant date set forth in column 3 above. /s/ Harry J. Leonhardt, Attorney-in-Fact 2021-07-26